Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis

Giulio Rossi, Giuliana Sartori, Alberto Cavazza, Stefano Tamberi

Research output: Contribution to journal › Article

31 Citations (Scopus)

Abstract

Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.

Original languageEnglish
Pages (from-to)159-160
Number of pages2
JournalLung Cancer
Volume63
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Mucoepidermoid Carcinoma
Differential Diagnosis
Adenosquamous Carcinoma
Lung
Mutation
Lung Neoplasms
Neoplasms

Keywords

  • EGFR
  • K-RAS
  • Lung
  • MUC5AC
  • Mucoepidermoid carcinoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis. / Rossi, Giulio; Sartori, Giuliana; Cavazza, Alberto; Tamberi, Stefano.

In: Lung Cancer, Vol. 63, No. 1, 01.2009, p. 159-160.

Research output: Contribution to journal › Article

Rossi, G, Sartori, G, Cavazza, A & Tamberi, S 2009, 'Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis', Lung Cancer, vol. 63, no. 1, pp. 159-160. https://doi.org/10.1016/j.lungcan.2008.09.007
Rossi G, Sartori G, Cavazza A, Tamberi S. Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis. Lung Cancer. 2009 Jan;63(1):159-160. https://doi.org/10.1016/j.lungcan.2008.09.007
Rossi, Giulio ; Sartori, Giuliana ; Cavazza, Alberto ; Tamberi, Stefano. / Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis. In: Lung Cancer. 2009 ; Vol. 63, No. 1. pp. 159-160.
@article{3d483e5349224475b175dea6af05c5ff,
title = "Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis",
abstract = "Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.",
keywords = "EGFR, K-RAS, Lung, MUC5AC, Mucoepidermoid carcinoma",
author = "Giulio Rossi and Giuliana Sartori and Alberto Cavazza and Stefano Tamberi",
year = "2009",
month = "1",
doi = "10.1016/j.lungcan.2008.09.007",
language = "English",
volume = "63",
pages = "159--160",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis

AU - Rossi, Giulio

AU - Sartori, Giuliana

AU - Cavazza, Alberto

AU - Tamberi, Stefano

PY - 2009/1

Y1 - 2009/1

N2 - Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.

AB - Mucoepidermoid carcinoma (MEC) of the lung needs to be carefully distinguished from other lung tumors with similar features, particularly from adenosquamous carcinoma, this latter tumor frequently showing EGFR mutations. In contrast with the data reported by Han et al in the last July issue of Lung Cancer, neither EGFR nor K-RAS mutations were observed in MEC from caucasian patients.

KW - EGFR

KW - K-RAS

KW - Lung

KW - MUC5AC

KW - Mucoepidermoid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=57649088341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649088341&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2008.09.007

DO - 10.1016/j.lungcan.2008.09.007

M3 - Article

C2 - 18992960

AN - SCOPUS:57649088341

VL - 63

SP - 159

EP - 160

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 1

ER -

Access to Document